feed,title,long_url,short_url
Benzinga,Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis,https://benzinga.com/general/biotech/22/09/29070956/regeneron-sanofis-flagship-dupixent-becomes-first-fda-approved-treatment-for-prurigo-nodularis,https://bit.ly/3y4D4Xf
Benzinga,"Idera Pharma Acquires Rare Disease Player, Names New CEO",https://benzinga.com/general/biotech/22/09/29074378/idera-pharma-acquires-rare-disease-player-names-new-ceo,https://bit.ly/3SCxK56
Benzinga,US Stocks Open Lower; Dow Drops 300 Points,https://benzinga.com/news/earnings/22/09/29074754/us-stocks-open-lower-dow-drops-300-points,https://bit.ly/3LSo6cw
